Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Goletti

Showing results (21-30 of 64) with videos related to

Pageof 7
Sort By:
AIDS Research and Human Retroviruses|April 10, 1997
Increased in vitro tetanus-induced production of HIV type 1 following in vivo immunization of HIV type 1-infected individuals with tetanus toxoidM A Ostrowski, S K Stanley, J S Justement, et al.
Immunity|June 1, 1995
Cross-linking of CD30 induces HIV expression in chronically infected T cellsP Biswas, C A Smith, D Goletti, et al.
Tuberculosis (Edinburgh, Scotland)|August 14, 2017
Analytical evaluation of QuantiFERON- Plus and QuantiFERON- Gold In-tube assays in subjects with or without tuberculosisE Petruccioli, V Vanini, T Chiacchio, et al.
International Journal of STD & AIDS|July 12, 2005
Pulmonary cryptosporidiosis in an AIDS patient: successful treatment with paromomycin plus azithromycinF Palmieri, S Cicalini, N Froio, et al.
Infection|October 17, 2002
The loss of CMV-specific CD27(-) T-cell effectors in a patient with recurrences of CMV retinitis is independent of HIV-1 viremiaG D'Offizi, V Ciapparoni, C Gioia, et al.
The European Respiratory Journal|July 18, 2009
Relationship of immunodiagnostic assays for tuberculosis and numbers of circulating CD4+ T-cells in HIV infectionL Leidl, H Mayanja-Kizza, G Sotgiu, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 17, 2006
Accuracy of an immune diagnostic assay based on RD1 selected epitopes for active tuberculosis in a clinical setting: a pilot studyD Goletti, S Carrara, D Vincenti, et al.
Scandinavian Journal of Immunology|September 17, 2016
Lack of Response to HBHA in HIV-Infected Patients with Latent Tuberculosis InfectionG Delogu, V Vanini, G Cuzzi, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 20, 2018
Diagnostic imaging of hepatic tuberculosis: case seriesV Schininà, F Albarello, M Cristofaro, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 21, 2018
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [I]: anti-tumor necrosis factor-α agents)J W Baddley, F Cantini, D Goletti, et al.
Pageof 7

Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
AIDS Research and Human Retroviruses|April 10, 1997
Increased in vitro tetanus-induced production of HIV type 1 following in vivo immunization of HIV type 1-infected individuals with tetanus toxoidM A Ostrowski, S K Stanley, J S Justement, et al.
Immunity|June 1, 1995
Cross-linking of CD30 induces HIV expression in chronically infected T cellsP Biswas, C A Smith, D Goletti, et al.
Tuberculosis (Edinburgh, Scotland)|August 14, 2017
Analytical evaluation of QuantiFERON- Plus and QuantiFERON- Gold In-tube assays in subjects with or without tuberculosisE Petruccioli, V Vanini, T Chiacchio, et al.
International Journal of STD & AIDS|July 12, 2005
Pulmonary cryptosporidiosis in an AIDS patient: successful treatment with paromomycin plus azithromycinF Palmieri, S Cicalini, N Froio, et al.
Infection|October 17, 2002
The loss of CMV-specific CD27(-) T-cell effectors in a patient with recurrences of CMV retinitis is independent of HIV-1 viremiaG D'Offizi, V Ciapparoni, C Gioia, et al.
The European Respiratory Journal|July 18, 2009
Relationship of immunodiagnostic assays for tuberculosis and numbers of circulating CD4+ T-cells in HIV infectionL Leidl, H Mayanja-Kizza, G Sotgiu, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 17, 2006
Accuracy of an immune diagnostic assay based on RD1 selected epitopes for active tuberculosis in a clinical setting: a pilot studyD Goletti, S Carrara, D Vincenti, et al.
Scandinavian Journal of Immunology|September 17, 2016
Lack of Response to HBHA in HIV-Infected Patients with Latent Tuberculosis InfectionG Delogu, V Vanini, G Cuzzi, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 20, 2018
Diagnostic imaging of hepatic tuberculosis: case seriesV Schininà, F Albarello, M Cristofaro, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 21, 2018
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [I]: anti-tumor necrosis factor-α agents)J W Baddley, F Cantini, D Goletti, et al.
Pageof 7